A next generation probabilistic approach to analyze cancer patients data with inference and applications
No Thumbnail Available
Date
2025
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This study addresses the critical challenges faced in cancer care, particularly in predicting survival times for
patients with lung cancer and acute myeloid leukemia. Despite recent advancements in medical science, existing
models often fall short in accurately capturing disease progression, leading to less effective clinical decision
making, and compromised patient outcomes. The need for advanced predictive models is urgent to improve
survival time forecasts and enhance treatment strategies. In response to this, we introduce a novel probabilistic
approach, the New Weibull (NEWE) model, which is part of a newly generated class designed to model cancer
patient data more effectively. Our methodology includes using seven well-known estimation methods, each
rigorously evaluated for consistency through Monte Carlo simulation studies focused on key metrics such as
absolute bias, mean square error, and mean relative error. The datasets analyzed include survival times for
twenty acute myeloid leukemia patients, 121 breast cancer patients from 1929 to 1938, 33 patients with acute
myelogenous leukemia, data from eighteen individuals who died from causes unrelated to cancer, and survival
times of advanced lung cancer patients undergoing standard chemotherapy. The NEWE model outperformed
competing models, particularly in Anderson-Darling, Cramer-von Mises, and Kolmogorov-Smirnov tests, with
significantly higher p-values. These findings highlight the NEWE model’s potential to transform predictive
oncology by offering more precise survival time predictions, improving the quality of care and decision-making
in cancer treatment.